CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $455 | -74.6% | 15,450 | -60.5% | 0.02% | -78.8% |
| Q4 2022 | $1,794 | -99.9% | 39,143 | 0.0% | 0.10% | -13.9% |
| Q3 2022 | $1,896,000 | +45.3% | 39,143 | +17.8% | 0.12% | +17.3% |
| Q2 2022 | $1,305,000 | +7.9% | 33,226 | +1.1% | 0.10% | +24.1% |
| Q1 2022 | $1,210,000 | +440.2% | 32,868 | +568.0% | 0.08% | +182.1% |
| Q4 2021 | $224,000 | -70.6% | 4,920 | -86.6% | 0.03% | -87.1% |
| Q4 2020 | $762,000 | +364.6% | 36,684 | +155.0% | 0.22% | +255.7% |
| Q3 2019 | $164,000 | -66.5% | 14,388 | -80.3% | 0.06% | -77.6% |
| Q3 2015 | $490,000 | -0.4% | 73,181 | 0.0% | 0.27% | +0.4% |
| Q2 2015 | $492,000 | -0.8% | 73,181 | 0.0% | 0.27% | -1.5% |
| Q1 2015 | $496,000 | -20.5% | 73,181 | -6.0% | 0.28% | -25.7% |
| Q4 2014 | $624,000 | +511.8% | 77,850 | +169.0% | 0.37% | +386.8% |
| Q3 2014 | $102,000 | +8.5% | 28,940 | +46.5% | 0.08% | +24.6% |
| Q2 2014 | $94,000 | – | 19,750 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |